List your tool

Head to head · 2026

CARPL.ai vs Proscia

Pricing, free plans, ratings, features, pros and cons, side by side. Where one comes out ahead, we mark it.

CARPL.ai

A vendor-neutral marketplace where radiologists test and deploy third-party AI algorithms against their own imaging data…

4.2Not listed

Visit CARPL.ai (opens CARPL.ai in a new tab)

Proscia

FDA-cleared digital pathology platform for primary diagnosis and biomarker research

4.3Not listed

Visit Proscia (opens Proscia in a new tab)

Who comes out ahead

Based only on the facts in our directory. The right pick still depends on the job you need done.

  • Lower starting price

    Not comparable

    Not comparable: CARPL.ai does not list a price

  • Free plan

    Tie

    Neither has one

  • Higher rating

    Proscia

    4.2 against 4.3

  • Same job?

    Yes

    Both are Healthcare AI tools

Side by side

Compared onCARPL.aiProscia
Our rating4.24.3Better
Starts atNot listedNot listed
Free planNoNo
CategoryHealthcare AIHealthcare AI
PlansSee pricingSee pricing
Key features
  • Marketplace access to 275+ third-party radiology AI applications
  • Universal AI viewer that standardizes output across vendors
  • On-premises testing of algorithms against a hospital's own data before deployment
  • Vendor-neutral structure covering 100+ AI vendors
  • FDA-cleared platform status
  • FDA-cleared for primary clinical diagnosis in AP-Dx
  • Concentriq AP, AP-Dx and LS configurations
  • Biomarker research and clinical trial workflows
  • Cloud deployment
  • Predetermined Change Control Plan for regulatory compliance
Pros
  • Vendor-neutral marketplace avoids locking a hospital into one AI vendor's roadmap
  • Lets radiology departments validate an algorithm on their own data before paying for full deployment
  • FDA clearance adds regulatory credibility uncommon among radiology AI marketplaces
  • FDA clearance for primary diagnosis, not just research viewing
  • Deployed across 4,000 hospitals and 16 of the top 20 pharma companies
  • Rated highest in KLAS 2026 in both the US and Europe
Cons
  • No published pricing, enterprise sales process required to get a quote
  • Built for institutional buyers, not useful for an individual radiologist or small clinic
  • Value depends on the quality of third-party algorithms in the marketplace, which CARPL does not itself build
  • No published pricing
  • Requires compatible scanning hardware
  • Adoption is a laboratory-wide programme, not a purchase
CompanyCARPL.ai, founded 2021Proscia Inc.

Prices come from each vendor's pricing page, last checked 20260814. Check the vendor before you buy.

FAQ

Questions people ask

Is CARPL.ai better than Proscia?

In our reviews CARPL.ai scores 4.2 and Proscia scores 4.3. The better pick depends on the job. CARPL.ai: A vendor-neutral marketplace where radiologists test and deploy third-party AI algorithms against their own imaging data behind their own firewall. Proscia: FDA-cleared digital pathology platform for primary diagnosis and biomarker research.

Which is cheaper, CARPL.ai or Proscia?

CARPL.ai: see pricing. Proscia: see pricing.

Do CARPL.ai and Proscia have free plans?

Neither lists a free plan.

More comparisons